Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Intergroup comparison for dialysis patients according to AVC level at baseline ( n= 67)

From: Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study

   No AVC Present AVC
N [n;%] 40; 60% 27; 40%
Gender (male) [n;%] 19; 48% 13; 48%
Age [yrs] 57 ± 16 63 ± 13
Time since first dialysis [mo]   76 ± 85 79 ± 81
BMI [kg/m2] 25 ± 5 26 ± 7
CAC Agatston   507 ± 794 918 ± 938
AVC Agatson   0 ± 0 189 ± 340
ucMGP [nmol/L] 2366 ± 791 2261 ± 589
Fetuin-A [g/L] 0.46 ± 0.11 0.46 ± 0.07
OPG [pmol/L] 4.96 ± 2.60 5.63 ± 2.819
Sclerostin [ng/mL] 1.35 ± 0.73 1.78 ± 0.84
CRP [mg/L] 7.77 ± 7.78 5.65 ± 4.55
iPTH [pg/mL] 242 ± 350 190 ± 301
BAP [U/L] 36 ± 30 27 ± 18
AP [U/L] 91 ± 60 79 ± 66
Total Ca2+ [mmol/L] 2.39 ±0.21 2.27 ± 0.36
Phosphorus [mmol/L] 1.76 ± 0.47 1.95 ± 0.63
Albumin [g/L] 39 ± 7 39 ± 4
Hb [g/L] 111 ± 14 108 ± 32
S-Creatinine [mg/dL] 9.2 ± 2.9 9.8 ± 3.0
S-Urea [mmol/L] 65 ± 59 81 ± 63